Omeprazole (A2845): Technical Guide for H+,K+-ATPase Inhibition

What This Product Solves

Omeprazole (SKU A2845), chemically known as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a benchmark tool for research that demands precise inhibition of the gastric proton pump. Its primary application is in preclinical workflows requiring robust, reproducible suppression of gastric acid secretion, including antiulcer activity studies and modeling of peptic ulcer disease. The compound's selectivity for H+,K+-ATPase, paired with a well-characterized IC50 profile, makes it suitable for dissecting proton pump mechanisms and evaluating new antiulcer strategies (source: product_spec).

Researchers facing challenges in assay sensitivity or reproducibility due to inconsistent inhibitor performance can leverage the high purity (≈98%) and documented potency of this formulation. Omeprazole is not suitable for diagnostic or therapeutic use, nor for studies outside gastric acid-related mechanisms, as clarified in the product documentation (source: product_spec).

For deeper insight into assay troubleshooting and workflow optimization, see the internal article "Omeprazole: Advanced H+,K+-ATPase Inhibitor for Gastric Acid Research", which details protocol enhancements and failure analysis. Practical guidance on handling and setup is also provided in "Omeprazole (A2845): Protocols for H+,K+-ATPase Inhibition Research".

Protocol Parameters

• assay: H+,K+-ATPase inhibition assay | value_with_unit: IC50 = 5.8 μM | applicability: Quantitative assessment of proton pump inhibition potency | rationale: Provides a benchmark for dose selection and activity comparison in gastric acid secretion research | source_type: product_spec
• assay: Histamine-induced gastric acid formation inhibition | value_with_unit: IC50 = 0.16 μM | applicability: Modeling of acid secretion response to physiological stimuli in vitro | rationale: Demonstrates sensitivity and efficacy for antiulcer activity studies | source_type: product_spec
• assay: Compound solubility for stock preparation | value_with_unit: ≥17.27 mg/mL in DMSO | applicability: Preparation of concentrated stock solutions for screening or dose-response protocols | rationale: Ensures accurate dosing and minimizes precipitation risk in experimental setups | source_type: product_spec
• assay: Storage conditions | value_with_unit: -20°C (solid); avoid long-term solution storage | applicability: Maintenance of compound stability and integrity for repeatable assay results | rationale: Prevents degradation that could confound experimental readout | source_type: product_spec
• assay: Purity (QC release) | value_with_unit: ~98% | applicability: Validates suitability for sensitive mechanistic studies and minimizes off-target effects | rationale: High purity reduces confounding variables in proton pump inhibition assays | source_type: product_spec

Workflow Setup and QC Checklist

• Weigh Omeprazole (A2845) as a solid under low-humidity conditions to avoid moisture uptake.
• Dissolve in DMSO to prepare a stock solution up to 17.27 mg/mL. Vortex until fully dissolved; do not use water or ethanol due to poor solubility (source: product_spec).
• Aliquot stocks, minimize freeze-thaw cycles, and store at -20°C. Avoid storing working solutions for extended periods; prepare fresh dilutions before each experiment.
• Equilibrate compound and assay buffers to room temperature before mixing to prevent precipitation.
• Use freshly prepared working solutions for each assay iteration to maintain potency and reproducibility.
• Monitor for visible precipitation or turbidity in assay wells, which may indicate exceeding DMSO solubility limits. Adjust dilution protocols accordingly.
• Include control conditions with equivalent DMSO concentration to account for solvent effects.
• Document lot number, preparation date, and storage conditions for each batch to ensure traceability and quality control.

Common Failure Modes and Fixes

• Incomplete dissolution in DMSO: If Omeprazole does not fully dissolve, verify that DMSO is anhydrous and at room temperature. Sonication or gentle heating (not exceeding 37°C) can aid dissolution, but avoid prolonged heat exposure to prevent degradation.
• Loss of inhibitory activity: Activity loss may result from repeated freeze-thaw cycles or prolonged storage of solutions. Always prepare fresh aliquots, store at -20°C as a solid, and discard unused working solutions after use.
• Precipitation in assay buffer: Precipitation typically indicates over-concentration or poor mixing. Dilute DMSO stock into buffer slowly with constant vortexing, and do not exceed recommended DMSO percentages in final assay.
• Assay interference from impurities: Use only product vials with QC-passed ~98% purity. Discard any material with visible discoloration or contamination.
• Variable inhibition in replicate assays: Confirm uniform compound distribution, proper mixing, and consistent timing across wells. Validate pipetting accuracy and use multi-channel pipettes for high-throughput workflows.

Scope and Limitations

Omeprazole (A2845) is strictly intended for research applications focused on gastric acid secretion mechanisms, antiulcer activity studies, and modeling of gastric acid-related disorders. Its use is not validated for clinical, diagnostic, or cross-domain biochemical assays unrelated to proton pump activity (source: product_spec). The compound’s efficacy and handling recommendations are grounded in product specifications, not in vivo or clinical datasets.

Solubility and stability are optimized for DMSO-based workflows; water or ethanol-based protocols are not supported due to negligible solubility. Researchers should not extrapolate the compound’s performance or safety profile to therapeutic contexts.

Conclusion

Omeprazole (A2845) provides researchers with a reliable, well-characterized H+,K+-ATPase inhibitor for precise modulation of gastric acid secretion in preclinical models. Careful adherence to solubility, storage, and handling guidelines is essential to maximize reproducibility and minimize assay variability. For protocol-specific troubleshooting and advanced applications, consult APExBIO resources and referenced internal articles. For further product details, visit the official page: Omeprazole.